Visionflex Group Limited (ASX:VFX) disclosed at its 2026 Annual General Meeting on 19 November 2026 that the company generated positive operating cash flow across the second half of FY26 for the first time, with the June 2026 quarter alone producing $0.7 million in operating cash inflow, while reported revenue for FY26 reached $4.2 million.
Key Points
- Visionflex generated positive operating cash flow in the second half of FY26, with $0.7 million of operating cash inflow in the June 2026 quarter.
- FY26 reported revenue was $4.2 million, 10% lower than the prior year, with the company attributing the difference to hardware order timing rather than lost revenue.
- Software and support revenue grew 27% to $1.7 million, representing 41% of total revenue, up from 29% a year earlier; gross margin increased to 86% from 78%.
- The company secured a $0.8 million statewide contract with NSW Health and $0.3 million in new contracts with the Royal Flying Doctor Service SA/NT.
- Group borrowings were reduced from $2.5 million to $0.6 million following conversion of $3.25 million of convertible notes into equity and a 50-for-1 share consolidation.
FY26 Financial Results and Balance Sheet Position
According to the filing, Visionflex's underlying EBITDA loss narrowed to $1.6 million in FY26 from $2.5 million in the prior comparative period. Customer cash receipts grew 8% to $4.9 million. Annual recurring revenue finished the year at $1.95 million, up 3%. The company's current ratio was above 1 for the first time in several years as at 30 June 2026 and net assets were close to breakeven. Full year operating and administration payments fell 18% in FY26 compared to the prior comparative period, following a workforce restructure completed in February 2026. As at 30 September 2026, the company held $0.66 million in cash, with a further $1.15 million available under undrawn facilities.
Key Customer Contracts Secured During FY26
The filing disclosed that Visionflex secured a $0.8 million contract with NSW Health to supply clinical hardware for its statewide Remote Patient Monitoring Digital Uplift initiative, described as the company's first statewide engagement with a public health system. The Royal Flying Doctor Service SA/NT agreement totalled $0.3 million, covering subscription upgrades at 12 existing facilities, expansion to eight further locations, and the first deployment of the company's unattended access capability. Amplar Health paid deployments under the Commonwealth-funded virtual nursing program grew from 10 to 30 facilities, and BlueCare Queensland renewed 26 facilities at uplifted subscription pricing. New contracts were also secured with Western NSW and Healthy North Coast Primary Health Networks, and with Origin Energy in the resources sector.
Unattended Access Product Launch and Recurring Revenue Challenges
The filing states that in the June quarter Visionflex launched its unattended access capability, which the Managing Director described as the most significant product development in the company's history, enabling a clinician to lead a complete consultation and operate clinical examination devices remotely with no operator required at the patient end. The company also disclosed that the move away from PHN-funded aged care reduced recurring revenue in the September quarter of FY27, identified as the main challenge of the first quarter of FY27. The Board's stated priority is a durably funded, cash-generative business supported by disciplined capital allocation and prudent risk management.




Please wait processing your request...